These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12079814)

  • 1. Women's health. Mammography: why is there a debate?
    Harv Health Lett; 2002 Jun; 27(8):4-5. PubMed ID: 12079814
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening--a cruel deception.
    Baum M
    Practitioner; 2002 May; 246(1634):293. PubMed ID: 12043346
    [No Abstract]   [Full Text] [Related]  

  • 3. Women's attitudes to false positive mammography results. A formerly clueless patient responds.
    Godby CJ
    BMJ; 2000 Dec; 321(7273):1409-10; discusson 1410-1. PubMed ID: 11187093
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods to identify benefit from mammographic screening of women aged 40-49 years.
    Feig SA
    Radiology; 1996 Nov; 201(2):309-16. PubMed ID: 8888216
    [No Abstract]   [Full Text] [Related]  

  • 5. US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey.
    Schwartz LM; Woloshin S; Sox HC; Fischhoff B; Welch HG
    West J Med; 2000 Nov; 173(5):307-12. PubMed ID: 11069862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breast carcinoma: successful early diagnosis, increased mortality].
    Paterok EM; Siebzehnrübl E; Schulz-Wendtland R; Koch T
    Rontgenpraxis; 1995 May; 48(5):125-31. PubMed ID: 7792664
    [No Abstract]   [Full Text] [Related]  

  • 7. Model of outcomes of screening mammography: women's decisions about screening depend on many factors.
    Lockwood SM; Bruce N; Manaszewicz R
    BMJ; 2005 Aug; 331(7512):351; author reply 351. PubMed ID: 16081456
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing breast cancer risk: evolution of the Gail Model.
    Bondy ML; Newman LA
    J Natl Cancer Inst; 2006 Sep; 98(17):1172-3. PubMed ID: 16954464
    [No Abstract]   [Full Text] [Related]  

  • 9. Women should be fully informed of the potential benefits and harms before screening mammography.
    Kerlikowske K; Ernster VL
    West J Med; 2000 Nov; 173(5):313-4. PubMed ID: 11069863
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening and diagnostic mammograms: why the gold standard does not shine more brightly.
    Sobti A; Sobti P; Keith LG
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):199-206. PubMed ID: 16468469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammograms: to screen or not to screen?
    Harv Womens Health Watch; 2002 Dec; 10(4):7. PubMed ID: 12499128
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution of mammography and echography to the diagnosis of breast cancer in Dakar: apropos of 25 cases].
    Diop-Ba S; Badiane M; Niang EH; Ly Ba A; Alfidja A; Favre Y
    Dakar Med; 1997; 42(2):114-7. PubMed ID: 9827132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decline in breast-cancer incidence.
    Cady B; Chung MA; Michaelson JS
    N Engl J Med; 2007 Aug; 357(5):511; author reply 513. PubMed ID: 17674459
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Robbins AS; Clarke CA
    J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
    [No Abstract]   [Full Text] [Related]  

  • 15. Computer-aided detection in full-field digital mammography: detection in dependence of the BI-RADS categories.
    Obenauer S; Sohns C; Werner C; Grabbe E
    Breast J; 2006; 12(1):16-9. PubMed ID: 16409582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Anderson BO
    J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
    Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
    Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bilateral carcinoma of the breast].
    Cucinotta E; Calbo L; Palmeri R; Pergolizzi FP; Melita G
    Chir Ital; 1997; 49(1-2):9-14. PubMed ID: 12743870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilated duct pattern at mammography.
    Huynh PT; Parellada JA; de Paredes ES; Harvey J; Smith D; Holley L; Maxin M
    Radiology; 1997 Jul; 204(1):137-41. PubMed ID: 9205235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.